dr. younes on ipi-145 and abt-199 for lymphoid malignancies
Published 10 years ago • 158 plays • Length 1:58Download video MP4
Download video MP3
Similar videos
-
1:55
dr. younes on ipi-145 and abt-199 in lymphoid malignancies
-
1:10
dr. younes discusses the future of treating lymphoid malignancies
-
2:04
dr. flinn on two ongoing clinical trials of ipi-145 for hematologic malignancies
-
2:49
julian adams, phd, on ipi-145 in hematologic malignancies
-
1:04
dr. younes on idelalisib in cll and inhl
-
0:54
dr. younes on brentuximab plus avd vs abvd in classical hodgkin lymphoma
-
1:12
dr. younes on the approval of ibrutinib for mcl
-
1:02
dr. younes on the implications of ibrutinib's approval for patients with mcl
-
2:13
dr. younes on r-chop in combination with ibrutinib in dlbcl
-
6:43
bcl-2 inhibition with abt-199 in cll, lymphomas
-
2:04
dr. brown gives an overview of abt-199 for the treatment of cll
-
1:23
dr. anas younes on impact of checkmate 205 in classical hodgkin lymphoma
-
1:18
preliminary results of a phase ib study combining abt-199 and obinutuzumab in cll
-
6:09
dr. linu abraham jacob, head of oncology, explains in detail how a liquid biopsy works
-
0:51
phase ii trial of ag-946 in patients with low-risk mds and anemia
-
1:42
dr. john seymour on the efficacy of abt-199 in high-risk cll
-
2:53
hudson: durvalumab combination therapies to overcome pd-l1 blockade resistance in advanced nsclc
-
1:21
dr. younes discusses fda approval of nivolumab in hodgkin lymphoma
-
3:27
ecco14: clinical trials of new breast cancer drug lapatinib.